CA2138264C - Preparation of compounds of lignan series - Google Patents
Preparation of compounds of lignan series Download PDFInfo
- Publication number
- CA2138264C CA2138264C CA002138264A CA2138264A CA2138264C CA 2138264 C CA2138264 C CA 2138264C CA 002138264 A CA002138264 A CA 002138264A CA 2138264 A CA2138264 A CA 2138264A CA 2138264 C CA2138264 C CA 2138264C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- preparation
- synthesis
- reaction
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 171
- 238000002360 preparation method Methods 0.000 title abstract description 83
- 229930013686 lignan Natural products 0.000 title abstract description 10
- 235000009408 lignans Nutrition 0.000 title abstract description 10
- 150000005692 lignans Chemical class 0.000 title abstract description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 118
- 238000000034 method Methods 0.000 claims abstract description 67
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 29
- -1 lactone compound Chemical class 0.000 claims abstract description 18
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 9
- 238000007259 addition reaction Methods 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 125000004953 trihalomethyl group Chemical group 0.000 claims description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 3
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 description 86
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 81
- 230000015572 biosynthetic process Effects 0.000 description 81
- 238000003786 synthesis reaction Methods 0.000 description 81
- 238000005160 1H NMR spectroscopy Methods 0.000 description 52
- 239000000243 solution Substances 0.000 description 51
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
- 238000002844 melting Methods 0.000 description 44
- 230000008018 melting Effects 0.000 description 44
- 239000000203 mixture Substances 0.000 description 44
- 101150041968 CDC13 gene Proteins 0.000 description 43
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 43
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- 235000012000 cholesterol Nutrition 0.000 description 17
- 125000005594 diketone group Chemical group 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 16
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 15
- 239000012267 brine Substances 0.000 description 15
- 239000012043 crude product Substances 0.000 description 15
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 6
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 4
- WMPDAIZRQDCGFH-UHFFFAOYSA-N 3-methoxybenzaldehyde Chemical compound COC1=CC=CC(C=O)=C1 WMPDAIZRQDCGFH-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- IMAKHNTVDGLIRY-UHFFFAOYSA-N methyl prop-2-ynoate Chemical compound COC(=O)C#C IMAKHNTVDGLIRY-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 4
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 4
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000008214 LDL Cholesterol Methods 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 2
- AXQACEQYCPKDMV-RZAWKFBISA-N (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy-n-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carboxamide Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3C(O)=C(C[C@]2(O)[C@]34CC1)C(=O)NC(C)(C)C=1ON=C(N=1)C=1C=CC=CC=1)CC1CC1 AXQACEQYCPKDMV-RZAWKFBISA-N 0.000 description 2
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 0 COC(c1c(C(*)=O)c(O)c(cc(*)c(*)c2*)c2c1-c(cc1*)ccc1O*)=O Chemical compound COC(c1c(C(*)=O)c(O)c(cc(*)c(*)c2*)c2c1-c(cc1*)ccc1O*)=O 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- DQBHLLPGTJOYAT-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-3-(4-methoxybenzoyl)-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=C(OC)C=C1 DQBHLLPGTJOYAT-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- RANYXVFYAIGDFE-UHFFFAOYSA-N 1,2,3-trimethoxynaphthalene Chemical compound C1=CC=C2C(OC)=C(OC)C(OC)=CC2=C1 RANYXVFYAIGDFE-UHFFFAOYSA-N 0.000 description 1
- KEIFWROAQVVDBN-UHFFFAOYSA-N 1,2-dihydronaphthalene Chemical compound C1=CC=C2C=CCCC2=C1 KEIFWROAQVVDBN-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- UNNGUFMVYQJGTD-UHFFFAOYSA-N 2-Ethylbutanal Chemical compound CCC(CC)C=O UNNGUFMVYQJGTD-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- KKKJYDOHVKIIQP-UHFFFAOYSA-N 2-[4-(3-chlorobenzoyl)phenoxy]-N-pyridin-3-ylacetamide Chemical compound ClC=1C=C(C(=O)C2=CC=C(OCC(=O)NC=3C=NC=CC=3)C=C2)C=CC=1 KKKJYDOHVKIIQP-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- LEKGYQWLMUVRGY-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-4,5,6-trimethoxy-3h-2-benzofuran-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1C2=C(OC)C(OC)=C(OC)C=C2C(=O)O1 LEKGYQWLMUVRGY-UHFFFAOYSA-N 0.000 description 1
- DNTVJEMGHBIUMW-IBGZPJMESA-N 3-[[4-[(1s)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid Chemical compound C1([C@H](C)N2N=C(C=C2C2=CC3=CC=C(C=C3C=C2)OC)C=2C=C(Cl)C=C(Cl)C=2)=CC=C(C(=O)NCCC(O)=O)C=C1 DNTVJEMGHBIUMW-IBGZPJMESA-N 0.000 description 1
- MWDVCHRYCKXEBY-LBPRGKRZSA-N 3-chloro-n-[2-oxo-2-[[(1s)-1-phenylethyl]amino]ethyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(Cl)=C1 MWDVCHRYCKXEBY-LBPRGKRZSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- HIJLVHXVBWTMEV-UHFFFAOYSA-N 3-ethylpentanal Chemical compound CCC(CC)CC=O HIJLVHXVBWTMEV-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- 125000002999 4-(trifluoromethyl)benzoyl group Chemical group FC(C1=CC=C(C(=O)*)C=C1)(F)F 0.000 description 1
- JOFDSYLCZIHGGO-UHFFFAOYSA-N 4-[(4-cyclohexylphenyl)methyl-[2-[[5-(dimethylamino)naphthalen-1-yl]sulfonyl-methylamino]acetyl]amino]-2-hydroxybenzoic acid Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)N(C)CC(=O)N(C=1C=C(O)C(C(O)=O)=CC=1)CC(C=C1)=CC=C1C1CCCCC1 JOFDSYLCZIHGGO-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- NJEAJBBKRDXYPX-UHFFFAOYSA-N 4h-naphthalen-1-one Chemical compound C1=CC=C2C(=O)C=CCC2=C1 NJEAJBBKRDXYPX-UHFFFAOYSA-N 0.000 description 1
- HSQGOSNQFMJSAI-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-5h-furo[3,4-f][1,3]benzodioxol-7-one Chemical compound C1=C(OC)C(OC)=CC=C1C1C2=CC(OCO3)=C3C=C2C(=O)O1 HSQGOSNQFMJSAI-UHFFFAOYSA-N 0.000 description 1
- CSQUXTSIDQURDV-UHFFFAOYSA-N 6-bromo-1,3-benzodioxole-5-carbaldehyde Chemical compound C1=C(C=O)C(Br)=CC2=C1OCO2 CSQUXTSIDQURDV-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 108010069201 VLDL Cholesterol Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 1
- PFCHFHIRKBAQGU-UHFFFAOYSA-N ethyl n-propyl ketone Natural products CCCC(=O)CC PFCHFHIRKBAQGU-UHFFFAOYSA-N 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- BYRPTKZOXNFFDB-UHFFFAOYSA-N lithium;bis(trimethylsilyl)azanide;oxolane Chemical compound [Li+].C1CCOC1.C[Si](C)(C)[N-][Si](C)(C)C BYRPTKZOXNFFDB-UHFFFAOYSA-N 0.000 description 1
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
- YTYMWWAQBLLQJP-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-3-(3-methoxybenzoyl)-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=CC(OC)=C1 YTYMWWAQBLLQJP-UHFFFAOYSA-N 0.000 description 1
- RTJZHFRZYWRJOB-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-3-(3-methylbenzoyl)-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=CC(C)=C1 RTJZHFRZYWRJOB-UHFFFAOYSA-N 0.000 description 1
- WWKBHHZGTQVHGM-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxo-3-[4-(trifluoromethyl)benzoyl]naphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 WWKBHHZGTQVHGM-UHFFFAOYSA-N 0.000 description 1
- MFKWWYDUOSOGBD-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-3-(2-ethylbutanoyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound C12=C(OC)C(OC)=C(OC)C=C2C(=O)C(C(=O)C(CC)CC)=C(C(=O)OC)C1(O)C1=CC=C(OC)C(OC)=C1 MFKWWYDUOSOGBD-UHFFFAOYSA-N 0.000 description 1
- OPKWYUQDCQFFJZ-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-3-(2-ethylbutanoyl)-4-hydroxy-6,7,8-trimethoxynaphthalene-2-carboxylate Chemical compound COC(=O)C=1C(C(=O)C(CC)CC)=C(O)C2=CC(OC)=C(OC)C(OC)=C2C=1C1=CC=C(OC)C(OC)=C1 OPKWYUQDCQFFJZ-UHFFFAOYSA-N 0.000 description 1
- JXHPHQZJLLADAD-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylpentanoyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound C12=C(OC)C(OC)=C(OC)C=C2C(=O)C(C(=O)CC(CC)CC)=C(C(=O)OC)C1(O)C1=CC=C(OC)C(OC)=C1 JXHPHQZJLLADAD-UHFFFAOYSA-N 0.000 description 1
- YQHHBVCALVLEJG-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxy-3-(2-methoxybenzoyl)naphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1OC YQHHBVCALVLEJG-UHFFFAOYSA-N 0.000 description 1
- GJYRSVWPANRUNT-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxy-3-(2-methylbenzoyl)naphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1C GJYRSVWPANRUNT-UHFFFAOYSA-N 0.000 description 1
- NZJPLJIRKJSEII-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxy-3-(3-methoxybenzoyl)naphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC(OC)=C1 NZJPLJIRKJSEII-UHFFFAOYSA-N 0.000 description 1
- LCHVYRAYDDKNDJ-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxy-3-(3-methylbenzoyl)naphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC(C)=C1 LCHVYRAYDDKNDJ-UHFFFAOYSA-N 0.000 description 1
- LSQPGWAQLSSMTI-UHFFFAOYSA-N methyl 1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxy-3-[4-(trifluoromethyl)benzoyl]naphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 LSQPGWAQLSSMTI-UHFFFAOYSA-N 0.000 description 1
- CSKSADNCHJPUQE-UHFFFAOYSA-N methyl 3-(2-chlorobenzoyl)-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1Cl CSKSADNCHJPUQE-UHFFFAOYSA-N 0.000 description 1
- MOXPLPBTUGFGON-UHFFFAOYSA-N methyl 3-(2-chlorobenzoyl)-1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxynaphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1Cl MOXPLPBTUGFGON-UHFFFAOYSA-N 0.000 description 1
- LLPQJCHGVJMZPD-UHFFFAOYSA-N methyl 3-(3,4-dichlorobenzoyl)-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=C(Cl)C(Cl)=C1 LLPQJCHGVJMZPD-UHFFFAOYSA-N 0.000 description 1
- XIVCUAYFCGLJJF-UHFFFAOYSA-N methyl 3-(3,4-dichlorobenzoyl)-1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxynaphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=C(Cl)C(Cl)=C1 XIVCUAYFCGLJJF-UHFFFAOYSA-N 0.000 description 1
- ROJYYOHMPIYDEC-UHFFFAOYSA-N methyl 3-(3-chlorobenzoyl)-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=CC(Cl)=C1 ROJYYOHMPIYDEC-UHFFFAOYSA-N 0.000 description 1
- OUSWFPUVAAZANY-UHFFFAOYSA-N methyl 3-(3-chlorobenzoyl)-1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxynaphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC(Cl)=C1 OUSWFPUVAAZANY-UHFFFAOYSA-N 0.000 description 1
- ZSUIPTHJXRYZHX-UHFFFAOYSA-N methyl 3-(4-chlorobenzoyl)-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=C(Cl)C=C1 ZSUIPTHJXRYZHX-UHFFFAOYSA-N 0.000 description 1
- PXYYQECMPBRALQ-UHFFFAOYSA-N methyl 3-(cyclohexanecarbonyl)-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1CCCCC1 PXYYQECMPBRALQ-UHFFFAOYSA-N 0.000 description 1
- MPIFPVJOKMRUIW-UHFFFAOYSA-N methyl 3-benzoyl-1-(3,4-dimethoxyphenyl)-1-hydroxy-6,7,8-trimethoxy-4-oxonaphthalene-2-carboxylate Chemical compound O=C1C2=CC(OC)=C(OC)C(OC)=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1 MPIFPVJOKMRUIW-UHFFFAOYSA-N 0.000 description 1
- KHBJOBLJLSXZSR-UHFFFAOYSA-N methyl 3-benzoyl-1-(3,4-dimethoxyphenyl)-4-hydroxy-6,7,8-trimethoxynaphthalene-2-carboxylate Chemical compound OC1=C2C=C(OC)C(OC)=C(OC)C2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=CC=C1 KHBJOBLJLSXZSR-UHFFFAOYSA-N 0.000 description 1
- KLJQQTNFQPUZKP-UHFFFAOYSA-N methyl 4-(2-chlorophenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC=C1Cl KLJQQTNFQPUZKP-UHFFFAOYSA-N 0.000 description 1
- MCGITOQTCIWHBJ-UHFFFAOYSA-N methyl 4-(2-methoxyphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC=C1OC MCGITOQTCIWHBJ-UHFFFAOYSA-N 0.000 description 1
- VUYYICDTTRSBDV-UHFFFAOYSA-N methyl 4-(2-methylphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC=C1C VUYYICDTTRSBDV-UHFFFAOYSA-N 0.000 description 1
- MZAOQXYPJIMZIY-UHFFFAOYSA-N methyl 4-(3,4-dichlorophenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(Cl)C(Cl)=C1 MZAOQXYPJIMZIY-UHFFFAOYSA-N 0.000 description 1
- RDPRCPXGDRGISQ-UHFFFAOYSA-N methyl 4-(3-chlorophenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC(Cl)=C1 RDPRCPXGDRGISQ-UHFFFAOYSA-N 0.000 description 1
- XFRQPCJUJIEIHY-UHFFFAOYSA-N methyl 4-(3-methoxyphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC(OC)=C1 XFRQPCJUJIEIHY-UHFFFAOYSA-N 0.000 description 1
- SYQMBIPVJQARKU-UHFFFAOYSA-N methyl 4-(3-methylphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC(C)=C1 SYQMBIPVJQARKU-UHFFFAOYSA-N 0.000 description 1
- ALNNWERTFHBQFA-UHFFFAOYSA-N methyl 4-(4-chlorophenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(Cl)C=C1 ALNNWERTFHBQFA-UHFFFAOYSA-N 0.000 description 1
- JKGUUADORVKPOJ-UHFFFAOYSA-N methyl 4-(4-methoxyphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(OC)C=C1 JKGUUADORVKPOJ-UHFFFAOYSA-N 0.000 description 1
- KZEPKSJCKHRDKP-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(C)C=C1 KZEPKSJCKHRDKP-UHFFFAOYSA-N 0.000 description 1
- PLBIDVBZBUCCFD-UHFFFAOYSA-N methyl 4-[4-(trifluoromethyl)phenyl]-4-trimethylsilyloxybut-2-ynoate Chemical compound COC(=O)C#CC(O[Si](C)(C)C)C1=CC=C(C(F)(F)F)C=C1 PLBIDVBZBUCCFD-UHFFFAOYSA-N 0.000 description 1
- JRUBUCYCDHVLEZ-UHFFFAOYSA-N methyl 4-cyclohexyl-4-hydroxybut-2-ynoate Chemical compound COC(=O)C#CC(O)C1CCCCC1 JRUBUCYCDHVLEZ-UHFFFAOYSA-N 0.000 description 1
- HTERTZZULNKIPD-UHFFFAOYSA-N methyl 4-cyclohexyl-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1CCCCC1 HTERTZZULNKIPD-UHFFFAOYSA-N 0.000 description 1
- SAZXSUIDPREHSA-UHFFFAOYSA-N methyl 4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(C(F)(F)F)C=C1 SAZXSUIDPREHSA-UHFFFAOYSA-N 0.000 description 1
- MSRRBJSMBKEECW-UHFFFAOYSA-N methyl 4-oxo-4-phenylbut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=CC=C1 MSRRBJSMBKEECW-UHFFFAOYSA-N 0.000 description 1
- YOTYGGPXSLPHGR-UHFFFAOYSA-N methyl 5-(3,4-dimethoxyphenyl)-5-hydroxy-8-oxo-7-[4-(trifluoromethyl)benzoyl]benzo[f][1,3]benzodioxole-6-carboxylate Chemical compound O=C1C2=CC=3OCOC=3C=C2C(C=2C=C(OC)C(OC)=CC=2)(O)C(C(=O)OC)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 YOTYGGPXSLPHGR-UHFFFAOYSA-N 0.000 description 1
- OVVXNTJKKAOGCO-UHFFFAOYSA-N methyl 5-ethyl-4-oxohept-2-ynoate Chemical compound CCC(CC)C(=O)C#CC(=O)OC OVVXNTJKKAOGCO-UHFFFAOYSA-N 0.000 description 1
- HTKITAGAGQHZGR-UHFFFAOYSA-N methyl 6-ethyl-4-oxooct-2-ynoate Chemical compound CCC(CC)CC(=O)C#CC(=O)OC HTKITAGAGQHZGR-UHFFFAOYSA-N 0.000 description 1
- VUCXVEMSVGJHBW-UHFFFAOYSA-N methyl 8-(3,4-dimethoxyphenyl)-4,5,6-trimethoxy-10-[4-(trifluoromethyl)benzoyl]-1-trimethylsilyloxy-11-oxatricyclo[6.2.1.02,7]undeca-2,4,6,9-tetraene-9-carboxylate Chemical compound C1=C(OC)C(OC)=C(OC)C2=C1C1(O[Si](C)(C)C)OC2(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 VUCXVEMSVGJHBW-UHFFFAOYSA-N 0.000 description 1
- GGCBZBAKJCXEDE-UHFFFAOYSA-N methyl 8-(3,4-dimethoxyphenyl)-5-hydroxy-6-[4-(trifluoromethyl)benzoyl]benzo[f][1,3]benzodioxole-7-carboxylate Chemical compound OC1=C2C=C3OCOC3=CC2=C(C=2C=C(OC)C(OC)=CC=2)C(C(=O)OC)=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 GGCBZBAKJCXEDE-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- RCSBCWXPGSPJNF-UHFFFAOYSA-N n-[4-[5-[3-chloro-4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]butyl]-4-(1,8-naphthyridin-2-yl)butanamide Chemical compound C1=C(Cl)C(OC(F)(F)F)=CC=C1C(O1)=NN=C1CCCCNC(=O)CCCC1=CC=C(C=CC=N2)C2=N1 RCSBCWXPGSPJNF-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HBEDNENASUYMPO-LJQANCHMSA-N n-hydroxy-4-[[(2r)-3-oxo-2-(thiophen-2-ylmethyl)-2,4-dihydroquinoxalin-1-yl]methyl]benzamide Chemical compound C1=CC(C(=O)NO)=CC=C1CN1C2=CC=CC=C2NC(=O)[C@H]1CC1=CC=CS1 HBEDNENASUYMPO-LJQANCHMSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- WNQRNJDWRMNXCZ-UHFFFAOYSA-N sodium;bis(triethylsilyl)azanide Chemical compound [Na+].CC[Si](CC)(CC)[N-][Si](CC)(CC)CC WNQRNJDWRMNXCZ-UHFFFAOYSA-N 0.000 description 1
- DZHAYSANSDYBFE-UHFFFAOYSA-N sodium;diethylazanide Chemical compound [Na+].CC[N-]CC DZHAYSANSDYBFE-UHFFFAOYSA-N 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8994493 | 1993-04-16 | ||
| JP089944/1993 | 1993-04-16 | ||
| PCT/JP1994/000612 WO1994024087A1 (fr) | 1993-04-16 | 1994-04-12 | Procede pour produire un compose de lignane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2138264A1 CA2138264A1 (en) | 1994-10-27 |
| CA2138264C true CA2138264C (en) | 2004-04-06 |
Family
ID=13984820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002138264A Expired - Fee Related CA2138264C (en) | 1993-04-16 | 1994-04-12 | Preparation of compounds of lignan series |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5488134A (enExample) |
| EP (1) | EP0646570B1 (enExample) |
| JP (1) | JP3411036B2 (enExample) |
| KR (1) | KR100277242B1 (enExample) |
| CN (1) | CN1046937C (enExample) |
| AT (1) | ATE167662T1 (enExample) |
| AU (1) | AU666819B2 (enExample) |
| CA (1) | CA2138264C (enExample) |
| DE (1) | DE69411243T2 (enExample) |
| DK (1) | DK0646570T3 (enExample) |
| ES (1) | ES2119190T3 (enExample) |
| TW (1) | TW255886B (enExample) |
| WO (1) | WO1994024087A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121060C (en) * | 1993-04-16 | 2004-04-06 | Sachio Mori | Preparation of lignan analogues |
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| KR100376281B1 (ko) * | 1995-12-26 | 2003-09-26 | 에스케이케미칼주식회사 | 리그난의 제조방법 |
| KR100389140B1 (ko) | 1997-09-29 | 2003-06-25 | 메이지 세이카 가부시키가이샤 | 삼환성 트리아졸로벤즈아제핀 유도체 및 그의 제조방법 및항알레르기제 |
| ATE242007T1 (de) | 1998-12-23 | 2003-06-15 | Searle Llc | Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen |
| EA005815B1 (ru) | 1998-12-23 | 2005-06-30 | Джи.Ди.Сирл Ллс | Комбинация ингибиторов транспорта желчных кислот в подвздошной кишке и ингибиторов белка, переносящего эфиры холестерина, для сердечно-сосудистых показаний |
| WO2000038722A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS |
| WO2000038728A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinations of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications |
| WO2000038724A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| ATE240120T1 (de) | 1998-12-23 | 2003-05-15 | Searle Llc | Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen |
| ATE242008T1 (de) | 1998-12-23 | 2003-06-15 | Searle Llc | Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen |
| WO2001068096A2 (en) * | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| EP1286984A2 (en) | 2000-03-10 | 2003-03-05 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
| BR0213501A (pt) | 2001-11-02 | 2004-08-24 | Searle Llc | Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato |
| WO2003061604A2 (en) | 2002-01-17 | 2003-07-31 | Pharmacia Corporation | Novel alkyl/aryl hydroxy or keto thiepines. |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| US20110294767A1 (en) | 2010-05-26 | 2011-12-01 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| AU2012328453B2 (en) | 2011-10-28 | 2017-05-04 | Shire Human Genetic Therapies, Inc. | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| ES2633766T3 (es) | 2011-10-28 | 2017-09-25 | Lumena Pharmaceuticals Llc | Inhibidores de reciclaje de ácido biliar para el tratamiento de enfermedades de hígado colestático pediátrico |
| KR20230152818A (ko) | 2013-03-15 | 2023-11-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제 |
| JP2016514678A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | バレット食道と胃食道逆流性疾患を処置するための胆汁酸再利用阻害剤 |
| ES2982943T3 (es) | 2019-02-12 | 2024-10-21 | Mirum Pharmaceuticals Inc | Métodos para aumentar el crecimiento en sujetos pediátricos con hepatopatía colestásica |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0372422A (ja) * | 1989-05-16 | 1991-03-27 | Tanabe Seiyaku Co Ltd | 抗脂血剤 |
| JPH03157351A (ja) * | 1989-11-13 | 1991-07-05 | Tanabe Seiyaku Co Ltd | ナフタレン誘導体及びその製法 |
| KR100252428B1 (ko) * | 1991-10-17 | 2000-04-15 | 시오노 요시히코 | 리그난유사체,이의제조방법및이를함유한항지혈증제 |
-
1994
- 1994-04-12 WO PCT/JP1994/000612 patent/WO1994024087A1/ja not_active Ceased
- 1994-04-12 EP EP94912092A patent/EP0646570B1/en not_active Expired - Lifetime
- 1994-04-12 CA CA002138264A patent/CA2138264C/en not_active Expired - Fee Related
- 1994-04-12 DE DE69411243T patent/DE69411243T2/de not_active Expired - Fee Related
- 1994-04-12 ES ES94912092T patent/ES2119190T3/es not_active Expired - Lifetime
- 1994-04-12 US US08/356,199 patent/US5488134A/en not_active Expired - Fee Related
- 1994-04-12 KR KR1019940704565A patent/KR100277242B1/ko not_active Expired - Fee Related
- 1994-04-12 AU AU64379/94A patent/AU666819B2/en not_active Ceased
- 1994-04-12 CN CN94190286A patent/CN1046937C/zh not_active Expired - Fee Related
- 1994-04-12 AT AT94912092T patent/ATE167662T1/de not_active IP Right Cessation
- 1994-04-12 DK DK94912092T patent/DK0646570T3/da active
- 1994-04-12 JP JP52298294A patent/JP3411036B2/ja not_active Expired - Fee Related
- 1994-04-18 TW TW083103432A patent/TW255886B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6437994A (en) | 1994-11-08 |
| EP0646570A4 (en) | 1995-08-09 |
| CN1109685A (zh) | 1995-10-04 |
| ATE167662T1 (de) | 1998-07-15 |
| DK0646570T3 (da) | 1998-10-26 |
| KR100277242B1 (ko) | 2001-02-01 |
| WO1994024087A1 (fr) | 1994-10-27 |
| DE69411243D1 (de) | 1998-07-30 |
| CA2138264A1 (en) | 1994-10-27 |
| TW255886B (enExample) | 1995-09-01 |
| US5488134A (en) | 1996-01-30 |
| JP3411036B2 (ja) | 2003-05-26 |
| KR950701902A (ko) | 1995-05-17 |
| DE69411243T2 (de) | 1998-11-19 |
| AU666819B2 (en) | 1996-02-22 |
| ES2119190T3 (es) | 1998-10-01 |
| EP0646570B1 (en) | 1998-06-24 |
| CN1046937C (zh) | 1999-12-01 |
| EP0646570A1 (en) | 1995-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2138264C (en) | Preparation of compounds of lignan series | |
| JP2559723B2 (ja) | ビニルフェノール誘導体 | |
| CA1069523A (en) | Process for preparing hypolipidaemiant products | |
| US4035376A (en) | Aroyl-substituted phenylacetic acid derivatives | |
| JPWO1994024087A1 (ja) | リグナン系化合物の製造方法 | |
| AU724665B2 (en) | Synthesis of terfenadine and derivatives | |
| US4060528A (en) | Aroyl-substituted phenylmalonic acid derivatives | |
| US5089654A (en) | Chalcone derivatives | |
| US5599952A (en) | Methods of producing carboxylic acid ester derivatives and intermediates for use in the methods | |
| US4153719A (en) | Aromatic diketones | |
| JP4881298B2 (ja) | インデノールエステルまたはエーテルの製造方法 | |
| US4042617A (en) | Process for preparing a 2-methyl-(substituted aryl)-pyruvic acid compound | |
| US4064132A (en) | Aroyl-substituted phenylacetamide derivatives | |
| JPS584699B2 (ja) | 置換フエニル酢酸誘導体及びその製法 | |
| US4414391A (en) | A process for preparing 2-pyridinyloxyphenoxy-lower-alkanoates | |
| JP2549997B2 (ja) | 新規ハロケタール化合物 | |
| CA2121060C (en) | Preparation of lignan analogues | |
| US4891433A (en) | Process for the preparation of dibenzothiepin derivative | |
| US4410716A (en) | Dibenzo[a,d]cycloheptene derivatives and process for production thereof | |
| GB1574583A (en) | Process for preparing thiazoles | |
| JP2801647B2 (ja) | ６―フルオロクロモン―２―カルボン酸誘導体の製造法 | |
| CA1072110A (en) | Process for preparing hypolipidaemiant products | |
| KR20000075700A (ko) | 4ｈ-4-옥소-퀴놀리진-3-카복실산 유도체의 제조방법 | |
| JP3869531B2 (ja) | ビフェニル誘導体の製造法 | |
| JP3467072B2 (ja) | リグナン類縁体の製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |